Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
worth $6 to $8?
Means half a billion bucks MC. With less than 3mil cash?
I am a bit afraid that this is going to be a perfect "sell on good news" story.
What should it bring to the SP if we get another tweet about the deal or an press article? Everybody knows already that the deal with GM will come with very high probability.
TOP NEWS out today!!
Actinium Presents New Pivotal Phase 3 SIERRA Trial Data Showing Rapid Peripheral Blast Reduction and Anti-Leukemic Effect with Single Agent Iomab-B in Older Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia at 2019 ASCO Annual Meeting.
https://web.tmxmoney.com/article.php?newsid=7481297048893155&qm_symbol=ATNM:US
Its going back upwards.
C´mon Workhorse - give us some nice RNS!!!
Pre-market loosk for a big dip.....
1,55 USD....
Could also be that many positioning in WKHS over the weekend since a RNS for finalized deal might be imminent...
Anyway.... Considering the pre-market activities it seems that we get a very interesting trading day for Workhorse shares.....
The question is if they MUST announce something now since Trump made that more or less concrete hint.....
Massively undervalued imho.
The public offering destroyed a lot of confidence nevertheless Iomab remains very promising!!
Abstract Highlighting New Data from the Iomab-B Pivotal Phase 3 SIERRA Trial to be Presented at 2019 ASCO Annual Meeting
NEW YORK, May 16, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced that an abstract pertaining to its lead product candidate, Iomab-B, which is being studied in the pivotal Phase 3 SIERRA study, will be presented via poster at the 2019 ASCO or American Society of Clinical Oncology Annual Meeting that is being held from May 31st – June 4th at McCormick Place, in Chicago. The data to be presented at ASCO is a new analysis from the first 25% of patients enrolled in the SIERRA trial highlighting that by day 3 after Iomab-B administration, patients had a 98% median reduction in peripheral blasts and 100% reduction in blasts by day 8. This significant and rapid reduction in blasts occurred with patients receiving only a single therapeutic infusion of Iomab-B and no other pre-transplant conditioning. As a result, patients had significantly lower circulating leukemia burden prior to their BMT or Bone Marrow Transplant with all patients that received a therapeutic infusion of Iomab-B having robust engraftment despite active disease prior to Iomab-B conditioning.
https://web.tmxmoney.com/article.php?newsid=5025873883549813&qm_symbol=ATNM:US
I guess Iomab will be a success.
Todays PR supports this imho!
GREAT News imho
SonyLIV partners with QYOU Media to launch 'The Q India'
Todays PR sounds good!!
Time for rebound is overdue.
....and what will Chevron do next?!
YES!! Occidental bids for Anadarko $76 per share which is 15% higher than Chevrons offer!!!
NEWS: American Pacific Mining Acquires the Historic Past-Producing Gooseberry Gold Project in Nevada, USA
https://web.tmxmoney.com/article.php?newsid=5764327285266482&qm_symbol=USGD:CNX
I meant "which is below last closing price".
Seems that the market does not like an offered price 0,385 USD which is below current SP.
Minus 30% is overreaction I guess. I have averaged down today.
Top-News:
Varian Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment
https://web.tmxmoney.com/article.php?newsid=5681732849682478&qm_symbol=VAR:US
Really nice chart!
New ATH today?
NEWS - Actinium Highlights Actimab-A and Venetoclax Synergies Observed in New Studies Presented at AACR
https://web.tmxmoney.com/article.php?newsid=7953264662678935&qm_symbol=ATNM:US
Really promising results!
AgraFlora makes strategic investment of $1.000.000 in Empower Clinics!
https://web.tmxmoney.com/article.php?newsid=4597077650726982&qm_symbol=AGRA:CNX
Current MC below ~ $9.2 Mio USD.
Cash and cash equivalents $16.5 Mio USD.
Overreaction.....
Sorry guys, the share price development of ATNM is pure nonsens and stock manipulation par excellence!
But SP goes down rapidly....
NEWS: NeutriSci and Naturally Splendid USA Announce Expanded Binding Terms of Partnership and Added Distribution of HempOmega™ and Cannabidiol (CBD) Sublingual Tablets
https://web.tmxmoney.com/article.php?newsid=7689643837070867&qm_symbol=NSP
Pre-Tax .285 / .285
NEWS:
Naturally Splendid Receives Investment Commitment for $2,000,000 from Wahupta Ventures Inc. for Cannabinoid Extraction Facility
https://web.tmxmoney.com/article.php?newsid=7483909505003298&qm_symbol=NSP
Just compare PREV with Tilray:
Tilray had $9,7Mio revenues in the last quarter:
https://www.sedar.com/GetFile.do?lang=EN&docClass=7&issuerNo=00045453&issuerType=03&projectNo=02817730&docId=4381395
So lets say $40Mio annually. Same as PREv now!
MC Tilray is $14 billion
MC PREV is 50 million
Only difference:
In the SP of Tilray the market priced in future revenue growth rates which should be much higher than PREV (Penta5).
But does this circumstance justify a MC which is 280 (!!!!) times higher than PREV?
Hey guys,
do you know what that means?
Penta5 has $42Mio annual revenues!
Based on that PREV´s p/s ratio goes from 600something to 1 just overnight.
As comparison:
The p/s ratio of the big cannabis company´s is 100 or even higher!
So PREV SP should be easily 10 times higher now. Just based on price / sales ratio!!!!
Anybody realized that already?
According the fact sheet they applied for dealer licence which is due in Q4 2018.
Uuups, we are already in Q4
NEWS out!
Redfund Client Biominerales Pharma Colombia Announces First Purchase Order
https://web.tmxmoney.com/article.php?newsid=5864527430213220&qm_symbol=LOAN:CNX
100% up yesterday with high volume but w/o news!
Something´s going on here.....
If we go above $0,80 the way is free.
Intraday new ATH @0,70 CAD
ASK 0,72
$$$$
Just google RxMM Health. They run the worlds largest hemp cultivation project!!
Redfund has its stake in it.
RxMM Ipo in Q4 2018!!
$$$$
And confirmed.
So new ATH at 0,69 CAD!
Still just 26Mio Cad MC!
0,69 Pre-ASK
It holds
$$$
If there isn´t good news potential in the pipeline they would not hire Marigold for promotion